{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:17:09Z","timestamp":1787847429292,"version":"build-2784847793"},"reference-count":74,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Immune-related ocular surface diseases, a group of diseases in which immune dysregulation damages the ocular surface, can induce uncontrolled inflammation and persistent epithelial defect, thus leading to the most severe forms of acute keratoconjunctivitis, dry eye disease, epithelial keratitis, stromal ulceration, and corneal perforation. As these diseases are often refractory to treatments, they have a threatening impact on the vision and life quality of patients. This review summarizes the current literature regarding the clinical application of sutured and self-retained cryopreserved amniotic membrane (AM) in treating Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis, ocular graft-versus-host disease, Sj\u00f6gren's syndrome, Mooren's ulcer, and peripheral ulcerative keratitis. Current evidence supports the safety and effectiveness of AM, especially self-retained cryopreserved AM, in decreasing ocular surface inflammation, promoting corneal epithelial and stromal healing, improving visual acuity, and preventing sight-threatening complications. Future studies are still required to validate the above findings and explore the varied application methods of AM to improve the clinical efficacy in maintaining ocular surface health.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/tjo.tjo_16_21","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T06:54:19Z","timestamp":1623826459000},"page":"132-140","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":25,"title":["Update on the application of amniotic membrane in immune-related ocular surface diseases"],"prefix":"10.4103","volume":"11","author":[{"given":"Ziyan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert Yuenhei","family":"Lao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20240830","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0161-6420(95)30811-1","article-title":"Analysis of the acute ophthalmic manifestations of the erythema multiforme\/Stevens-Johnson syndrome\/toxic epidermal necrolysis disease spectrum","volume":"102","author":"Power","year":"1995","journal-title":"Ophthalmology"},{"key":"R2-4-20240830","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.survophthal.2009.03.004","article-title":"Amniotic membrane transplantation as a new therapy for the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"54","author":"Shay","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"R3-4-20240830","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jtos.2020.03.004","article-title":"Long-term outcomes of amniotic membrane treatment in acute Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"18","author":"Shanbhag","year":"2020","journal-title":"Ocul Surf"},{"key":"R4-4-20240830","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ajo.2016.03.020","article-title":"Ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in children","volume":"166","author":"Catt","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"R5-4-20240830","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0161-6420(01)00900-9","article-title":"Amniotic membrane in the surgical management of acute toxic epidermal necrolysis","volume":"109","author":"John","year":"2002","journal-title":"Ophthalmology"},{"key":"R6-4-20240830","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.2147\/OPTH.S208008","article-title":"Amniotic membrane transplantation in ophthalmology: An updated perspective","volume":"14","author":"Walkden","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"R7-4-20240830","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ophtha.2015.10.027","article-title":"Adjuvant role of amniotic membrane transplantation in acute ocular Stevens-Johnson syndrome: A randomized control trial","volume":"123","author":"Sharma","year":"2016","journal-title":"Ophthalmology"},{"key":"R8-4-20240830","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/ICO.0b013e31823d02a8","article-title":"Indications and outcomes of amniotic membrane transplantation in the management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis: A case-control study","volume":"31","author":"Hsu","year":"2012","journal-title":"Cornea"},{"key":"R9-4-20240830","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/ICU.0b013e3283622718","article-title":"Current ophthalmologic treatment strategies for acute and chronic Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"24","author":"Ciralsky","year":"2013","journal-title":"Curr Opin Ophthalmol"},{"key":"R10-4-20240830","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/archopht.121.10.1369","article-title":"Amniotic membrane with living related corneal limbal\/conjunctival allograft for ocular surface reconstruction in Stevens-Johnson syndrome","volume":"121","author":"Gomes","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R11-4-20240830","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.ophtha.2004.11.041","article-title":"Intraoperative mitomycin C and amniotic membrane transplantation for fornix reconstruction in severe cicatricial ocular surface diseases","volume":"112","author":"Tseng","year":"2005","journal-title":"Ophthalmology"},{"key":"R12-4-20240830","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jtos.2019.01.003","article-title":"The application of human amniotic membrane in the surgical management of limbal stem cell deficiency","volume":"17","author":"Le","year":"2019","journal-title":"Ocul Surf"},{"key":"R13-4-20240830","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/tjo.tjo_5_20","article-title":"Amniotic membrane transplantation for managing dry eye and neurotrophic keratitis","volume":"10","author":"Mead","year":"2020","journal-title":"Taiwan J Ophthalmol"},{"key":"R14-4-20240830","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1586\/eop.10.63","article-title":"Update on amniotic membrane transplantation","volume":"5","author":"Liu","year":"2010","journal-title":"Expert Rev Ophthalmol"},{"key":"R15-4-20240830","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/bjo.85.4.444","article-title":"Suppression of interleukin 1alpha and interleukin 1beta in human limbal epithelial cells cultured on the amniotic membrane stromal matrix","volume":"85","author":"Solomon","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"R16-4-20240830","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1177\/0363546515612750","article-title":"Human amniotic membrane-derived products in sports medicine: Basic science, early results, and potential clinical applications","volume":"44","author":"Riboh","year":"2016","journal-title":"Am J Sports Med"},{"key":"R17-4-20240830","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1076\/0271-3683(200004)2041-5FT325","article-title":"Suppression of TGF-beta signaling in both normal conjunctival fibroblasts and pterygial body fibroblasts by amniotic membrane","volume":"20","author":"Lee","year":"2000","journal-title":"Curr Eye Res"},{"key":"R18-4-20240830","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.icu.0000172827.31985.3a","article-title":"Amniotic membrane use in ophthalmology","volume":"16","author":"Gomes","year":"2005","journal-title":"Curr Opin Ophthalmol"},{"key":"R19-4-20240830","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00003226-199509000-00006","article-title":"Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas","volume":"14","author":"Kim","year":"1995","journal-title":"Cornea"},{"key":"R20-4-20240830","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0161-6420(00)00024-5","article-title":"Amniotic membrane transplantation for acute chemical or thermal burns","volume":"107","author":"Meller","year":"2000","journal-title":"Ophthalmology"},{"key":"R21-4-20240830","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.2147\/OPTH.S253750","article-title":"Self-retained cryopreserved amniotic membrane for the management of corneal ulcers","volume":"14","author":"Brocks","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"R22-4-20240830","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0002-9394(14)70125-4","article-title":"Amniotic membrane transplantation for persistent epithelial defects with ulceration","volume":"123","author":"Lee","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"R23-4-20240830","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0002-9394(14)71693-9","article-title":"Amniotic membrane transplantation for conjunctival surface reconstruction","volume":"124","author":"Tseng","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"R24-4-20240830","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0161-6420(00)00567-4","article-title":"Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia","volume":"108","author":"Solomon","year":"2001","journal-title":"Ophthalmology"},{"key":"R25-4-20240830","first-page":"243","article-title":"Amniotic membrane transplantation in the human eye","volume":"108","author":"Meller","year":"2011","journal-title":"Dtsch Arztebl Int"},{"key":"R26-4-20240830","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/ICO.0b013e3181acf816","article-title":"Efficacy and limitation of sutureless amniotic membrane transplantation for acute toxic epidermal necrolysis","volume":"29","author":"Shay","year":"2010","journal-title":"Cornea"},{"key":"R27-4-20240830","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ajo.2019.07.006","article-title":"Long-term effect of a treatment protocol for acute ocular involvement in Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"208","author":"Shanbhag","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"R28-4-20240830","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jtos.2016.02.001","article-title":"Acute and chronic ophthalmic involvement in Stevens-Johnson syndrome\/toxic epidermal necrolysis \u2013 A comprehensive review and guide to therapy. II. Ophthalmic disease","volume":"14","author":"Kohanim","year":"2016","journal-title":"Ocul Surf"},{"key":"R29-4-20240830","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1136\/bjo.2007.131102","article-title":"Technique of amniotic membrane transplant dressing in the management of acute Stevens-Johnson syndrome","volume":"91","author":"Muqit","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R30-4-20240830","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/ICO.0000000000000254","article-title":"Amnion doughnut: A novel method for sutureless fixation of amniotic membrane to the bulbar and palpebral conjunctiva in acute ocular-involving Stevens-Johnson syndrome","volume":"33","author":"Pruet","year":"2014","journal-title":"Cornea"},{"key":"R31-4-20240830","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/pde.14376","article-title":"Infantile toxic epidermal necrolysis: Successful treatment of an 8-week-old with intravenous immunoglobulin and amniotic membrane transplant","volume":"38","author":"Nassim","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"R32-4-20240830","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ajo.2015.05.002","article-title":"Predictive factors associated with acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"160","author":"Sotozono","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"R33-4-20240830","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ophtha.2011.01.046","article-title":"Treatment of acute Stevens-Johnson syndrome and toxic epidermal necrolysis using amniotic membrane: A review of 10 consecutive cases","volume":"118","author":"Gregory","year":"2011","journal-title":"Ophthalmology"},{"key":"R35-4-20240830","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaapos.2017.04.002","article-title":"Amniotic membrane transplants in the pediatric population","volume":"21","author":"Ahmad","year":"2017","journal-title":"J AAPOS"},{"key":"R36-4-20240830","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3126\/nepjoph.v7i2.14969","article-title":"Amniotic membrane transplantation (AMT) without the use of sutures\/fibrin glue","volume":"7","author":"Agrawal","year":"2015","journal-title":"Nepal J Ophthalmol"},{"key":"R37-4-20240830","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jtos.2015.07.002","article-title":"A novel technique for amniotic membrane transplantation in patients with acute Stevens-Johnson syndrome","volume":"14","author":"Ma","year":"2016","journal-title":"Ocul Surf"},{"key":"R38-4-20240830","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3341\/kjo.2013.27.5.331","article-title":"Effect of age and early intervention with a systemic steroid, intravenous immunoglobulin or amniotic membrane transplantation on the ocular outcomes of patients with Stevens-Johnson syndrome","volume":"27","author":"Kim","year":"2013","journal-title":"Korean J Ophthalmol"},{"key":"R39-4-20240830","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ajo.2009.08.040","article-title":"Management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis utilizing amniotic membrane and topical corticosteroids","volume":"149","author":"Shammas","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"R40-4-20240830","doi-asserted-by":"crossref","first-page":"101017","DOI":"10.1016\/j.ajoc.2021.101017","article-title":"Amniotic membrane transplantation in a 2-month-old infant with toxic epidermal necrolysis","volume":"21","author":"Elhusseiny","year":"2021","journal-title":"Am J Ophthalmol Case Rep"},{"key":"R42-4-20240830","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/ICO.0000000000000770","article-title":"Successful treatment of acute ocular-involving toxic epidermal necrolysis using amniotic membrane suture fixated to custom designed symblepharon rings","volume":"35","author":"Cheung","year":"2016","journal-title":"Cornea"},{"key":"R43-4-20240830","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/ICU.0000000000000312","article-title":"Ocular manifestations of Stevens-Johnson syndrome and their management","volume":"27","author":"Saeed","year":"2016","journal-title":"Curr Opin Ophthalmol"},{"key":"R44-4-20240830","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajo.2018.01.028","article-title":"Chronic ocular sequelae of Stevens-Johnson syndrome in children: Long-term impact of appropriate therapy on natural history of disease","volume":"189","author":"Basu","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"R45-4-20240830","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0161-6420(00)00026-9","article-title":"Amniotic membrane transplantation for ocular surface reconstruction in Stevens-Johnson syndrome","volume":"107","author":"Honavar","year":"2000","journal-title":"Ophthalmology"},{"key":"R46-4-20240830","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jtos.2019.03.001","article-title":"Sutureless amniotic membrane transplantation with cyanoacrylate glue for acute Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"17","author":"Shanbhag","year":"2019","journal-title":"Ocul Surf"},{"key":"R47-4-20240830","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/01.ico.0000151547.08113.d1","article-title":"Amniotic membrane transplantation and fibrin glue in the management of corneal ulcers and perforations: A review of 33 cases","volume":"24","author":"Hick","year":"2005","journal-title":"Cornea"},{"key":"R48-4-20240830","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ajo.2015.06.003","article-title":"Sealing of the gap between the conjunctiva and tenon capsule to improve symblepharon surgery","volume":"160","author":"Zhao","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"R49-4-20240830","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/ICO.0b013e318247983d","article-title":"A combined approach of amniotic membrane and oral mucosa transplantation for fornix reconstruction in severe symblepharon","volume":"32","author":"Kheirkhah","year":"2013","journal-title":"Cornea"},{"key":"R50-4-20240830","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0161-6420(02)01441-0","article-title":"Amniotic membrane transplantation for reconstruction of the conjunctival fornices","volume":"110","author":"Solomon","year":"2003","journal-title":"Ophthalmology"},{"key":"R51-4-20240830","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"R52-4-20240830","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.survophthal.2012.08.004","article-title":"Ocular graft-versus-host disease: A review","volume":"58","author":"Shikari","year":"2013","journal-title":"Surv Ophthalmol"},{"key":"R53-4-20240830","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ajo.2020.05.035","article-title":"Prevalence of persistent corneal epithelial defects in chronic ocular graft-versus-host disease","volume":"218","author":"Sinha","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"R54-4-20240830","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00417-019-04301-6","article-title":"Ocular surface system alterations in ocular graft-versus-host disease: All the pieces of the complex puzzle","volume":"257","author":"Giannaccare","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R55-4-20240830","doi-asserted-by":"crossref","first-page":"100761","DOI":"10.1016\/j.ajoc.2020.100761","article-title":"Self-retained cryopreserved amniotic membrane in treating acute ocular graft-versus-host-disease (oGVHD)","volume":"19","author":"Yin","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"key":"R56-4-20240830","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/s41409-018-0140-6","article-title":"Amniotic membrane transplantation-a new approach to crossing the HLA barriers in the treatment of refractory ocular graft-versus-host disease","volume":"53","author":"Peric","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"R57-4-20240830","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/112067210101100215","article-title":"Multilayer amniotic membrane transplantation in severe ocular graft versus host disease","volume":"11","author":"Peris-Mart\u00ednez","year":"2001","journal-title":"Eur J Ophthalmol"},{"key":"R58-4-20240830","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0929-6646(09)60125-X","article-title":"Recurrent corneal perforation and acute calcareous corneal degeneration in chronic graft-versus-host disease","volume":"105","author":"Yeh","year":"2006","journal-title":"J Formos Med Assoc"},{"key":"R59-4-20240830","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4103\/2008-322X.180705","article-title":"Recurrent corneal perforation due to chronic graft versus host disease; a clinicopathologic report","volume":"11","author":"Mohammadpour","year":"2016","journal-title":"J Ophthalmic Vis Res"},{"key":"R60-4-20240830","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.survophthal.2019.10.004","article-title":"Primary Sj\u00f6gren's syndrome and the eye","volume":"65","author":"Bjordal","year":"2020","journal-title":"Surv Ophthalmol"},{"key":"R61-4-20240830","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/ICO.0000000000001865","article-title":"Sj\u00f6gren's syndrome: More than just dry eye","volume":"38","author":"Akpek","year":"2019","journal-title":"Cornea"},{"key":"R62-4-20240830","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5693\/djo.01.2019.02.005","article-title":"The use of self-retained, cryopreserved amniotic membrane for the treatment of Sj\u00f6gren syndrome: A case series","volume":"25","author":"Shafer","year":"2019","journal-title":"Digit J Ophthalmol"},{"key":"R63-4-20240830","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4103\/tjo.tjo_3_19","article-title":"Bilateral corneal melting associated with topical diclofenac 0.1% after cataract surgery in a patient with Sj\u00f6gren's syndrome","volume":"9","author":"Tu","year":"2019","journal-title":"Taiwan J Ophthalmol"},{"key":"R64-4-20240830","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-0032-1328394","article-title":"Long-term follow-up of multilayer amniotic membrane transplantation (MLAMT) for non-traumatic corneal perforations or deep ulcers with descemetocele","volume":"230","author":"Berguiga","year":"2013","journal-title":"Klin Monbl Augenheilkd"},{"key":"R65-4-20240830","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s10792-017-0708-y","article-title":"Adjunctive role of self-retained cryopreserved amniotic membrane in treating immune-related dry eye disease","volume":"38","author":"Cheng","year":"2018","journal-title":"Int Ophthalmol"},{"key":"R66-4-20240830","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0002-9394(00)00825-4","article-title":"Multilayered amniotic membrane transplantation for severe ulceration of the cornea and sclera","volume":"131","author":"Hanada","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R67-4-20240830","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0161-6420(01)01032-6","article-title":"Amniotic membrane grafts for nontraumatic corneal perforations, descemetoceles, and deep ulcers","volume":"109","author":"Solomon","year":"2002","journal-title":"Ophthalmology"},{"key":"R68-4-20240830","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ophtha.2003.06.024","article-title":"Relapsing Mooren's ulcer after amniotic membrane transplantation combined with conjunctival autografting","volume":"111","author":"Chen","year":"2004","journal-title":"Ophthalmology"},{"key":"R69-4-20240830","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1442-9071.2010.02479.x","article-title":"Amniotic membrane transplantation for Mooren's ulcer","volume":"39","author":"Ngan","year":"2011","journal-title":"Clin Exp Ophthalmol"},{"key":"R70-4-20240830","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1136\/bjo.85.12.1455","article-title":"Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation","volume":"85","author":"Prabhasawat","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"R71-4-20240830","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/ICO.0000000000000130","article-title":"Combined anterior chamber washout, amniotic membrane transplantation, and topical use of corticosteroids for severe peripheral ulcerative keratitis","volume":"33","author":"Jia","year":"2014","journal-title":"Cornea"},{"key":"R72-4-20240830","doi-asserted-by":"crossref","first-page":"7403842","DOI":"10.1155\/2020\/7403842","article-title":"Lamellar keratoplasty combined with amniotic membrane transplantation for the treatment of corneal perforations: A clinical and in vivo confocal microscopy study","volume":"2020","author":"Ke","year":"2020","journal-title":"Biomed Res Int"},{"key":"R73-4-20240830","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/ICO.0000000000002317","article-title":"Peripheral ulcerative keratitis secondary to atypical hemolytic Uremic syndrome","volume":"39","author":"Mishra","year":"2020","journal-title":"Cornea"},{"key":"R75-4-20240830","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/01.ico.0000214216.75496.7e","article-title":"Mooren ulcer: An immunopathologic study","volume":"25","author":"Kafkala","year":"2006","journal-title":"Cornea"},{"key":"R76-4-20240830","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2415-13-81","article-title":"Amniotic membrane transplantation ineffective as additional therapy in patients with aggressive Mooren's ulcer","volume":"13","author":"Schallenberg","year":"2013","journal-title":"BMC Ophthalmol"},{"key":"R77-4-20240830","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2147\/OPTH.S165553","article-title":"Amniotic membrane extract and eye drops: A review of literature and clinical application","volume":"12","author":"Murri","year":"2018","journal-title":"Clin Ophthalmol"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.tjo_16_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:17:40Z","timestamp":1787843860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.tjo_16_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/tjo.tjo_16_21","relation":{},"ISSN":["2211-5056"],"issn-type":[{"value":"2211-5056","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}